Complete Eye Ophthalmoplegia: the Unusual Initial Presentation of Leptomeningeal Carcinomatosis

Overview

Journal J Community Hosp Intern Med Perspect

Date 2019 Sep 19

PMID 31528289

Citations 1

Authors

Lakshpaul Chauhan

Ateeq Mubarik

Abdulmagid Eddib

Mohammad Eid

Ali Vaziri

Salman Muddassir

Affiliations

Soon will be listed here.

Abstract

Ophthalmoplegia is a paralysis or weakness of extraocular muscles that have a variety of different etiologies including and not limited to Leptomeningeal Carcinomatosis (LC). LC is caused mainly by metastatic cancers and can cause a wide variety of symptoms. We present a case of LC with no preexisting condition who presented with a unilateral ophthalmoplegia as initial presentation who was found to have LC secondary to large B-cell lymphoma.

Citing Articles

Ophthalmoplegia in a Her2+ and β-hCG+ Patient With Leptomeningeal Carcinomatosis Secondary to Gastric Adenocarcinoma.

Falk Z, Bou Nasif M, Fallouh N Cureus. 2022; 14(7):e26658.

PMID: 35815304 PMC: 9266915. DOI: 10.7759/cureus.26658.

References

Collie D, Brush J, Lammie G, Grant R, Kunkler I, Leonard R . Imaging features of leptomeningeal metastases. Clin Radiol. 1999; 54(11):765-71. DOI: 10.1016/s0009-9260(99)91181-9. View

Nakatsuji Y, Sadahiro S, Watanabe S, Fujimura H, Abe K, Koguchi K . Leptomeningeal signet-ring cell carcinomatosis presenting with ophthalmoplegia, areflexia and ataxia. Clin Neuropathol. 2002; 20(6):272-5. View

Herrlinger U, Forschler H, Kuker W, Meyermann R, Bamberg M, Dichgans J . Leptomeningeal metastasis: survival and prognostic factors in 155 patients. J Neurol Sci. 2004; 223(2):167-78. DOI: 10.1016/j.jns.2004.05.008. View

Schinstine M, Filie A, Wilson W, Stetler-Stevenson M, Abati A . Detection of malignant hematopoietic cells in cerebral spinal fluid previously diagnosed as atypical or suspicious. Cancer. 2006; 108(3):157-62. DOI: 10.1002/cncr.21915. View

Rudnicka H, Niwinska A, Murawska M . Breast cancer leptomeningeal metastasis--the role of multimodality treatment. J Neurooncol. 2007; 84(1):57-62. DOI: 10.1007/s11060-007-9340-4. View

Waki F, Ando M, Takashima A, Yonemori K, Nokihara H, Miyake M . Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors. J Neurooncol. 2008; 93(2):205-12. DOI: 10.1007/s11060-008-9758-3. View

Clarke J, Perez H, Jacks L, Panageas K, DeAngelis L . Leptomeningeal metastases in the MRI era. Neurology. 2010; 74(18):1449-54. PMC: 2871005. DOI: 10.1212/WNL.0b013e3181dc1a69. View

Beauchesne P . Intrathecal chemotherapy for treatment of leptomeningeal dissemination of metastatic tumours. Lancet Oncol. 2010; 11(9):871-9. DOI: 10.1016/S1470-2045(10)70034-6. View

Souchon R, Feyer P, Thomssen C, Fehm T, Diel I, Nitz U . Clinical Recommendations of DEGRO and AGO on Preferred Standard Palliative Radiotherapy of Bone and Cerebral Metastases, Metastatic Spinal Cord Compression, and Leptomeningeal Carcinomatosis in Breast Cancer. Breast Care (Basel). 2011; 5(6):401-7. PMC: 3076353. DOI: 10.1159/000322661. View

10.

Morris P, Reiner A, Szenberg O, Clarke J, Panageas K, Perez H . Leptomeningeal metastasis from non-small cell lung cancer: survival and the impact of whole brain radiotherapy. J Thorac Oncol. 2011; 7(2):382-5. DOI: 10.1097/JTO.0b013e3182398e4f. View

11.

Hyun J, Jeong I, Joung A, Cho H, Kim S, Kim H . Leptomeningeal metastasis: Clinical experience of 519 cases. Eur J Cancer. 2016; 56:107-114. DOI: 10.1016/j.ejca.2015.12.021. View

12.

Danieli L, Montali M, Remonda L, Killer H, Colosimo C, Cianfoni A . Clinically Directed Neuroimaging of Ophthalmoplegia. Clin Neuroradiol. 2017; 28(1):3-16. DOI: 10.1007/s00062-017-0646-0. View

13.

Wang N, Bertalan M, Brastianos P . Leptomeningeal metastasis from systemic cancer: Review and update on management. Cancer. 2017; 124(1):21-35. PMC: 7418844. DOI: 10.1002/cncr.30911. View

14.

El Shafie R, Bohm K, Weber D, Lang K, Schlaich F, Adeberg S . Outcome and prognostic factors following palliative craniospinal irradiation for leptomeningeal carcinomatosis. Cancer Manag Res. 2019; 11:789-801. PMC: 6340499. DOI: 10.2147/CMAR.S182154. View

15.

Olson M, Chernik N, Posner J . Infiltration of the leptomeninges by systemic cancer. A clinical and pathologic study. Arch Neurol. 1974; 30(2):122-37. DOI: 10.1001/archneur.1974.00490320010002. View

16.

Wasserstrom W, Glass J, Posner J . Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer. 1982; 49(4):759-72. DOI: 10.1002/1097-0142(19820215)49:4<759::aid-cncr2820490427>3.0.co;2-7. View

17.

Boyle R, Thomas M, Adams J . Diffuse involvement of the leptomeninges by tumour--a clinical and pathological study of 63 cases. Postgrad Med J. 1980; 56(653):149-58. PMC: 2425846. DOI: 10.1136/pgmj.56.653.149. View

18.

Siegal T, Lossos A, Pfeffer M . Leptomeningeal metastases: analysis of 31 patients with sustained off-therapy response following combined-modality therapy. Neurology. 1994; 44(8):1463-9. DOI: 10.1212/wnl.44.8.1463. View

19.

Glantz M, Cole B, Glantz L, Cobb J, Mills P, Lekos A . Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results. Cancer. 1998; 82(4):733-9. DOI: 10.1002/(sici)1097-0142(19980215)82:4<733::aid-cncr17>3.0.co;2-z. View

20.

Chamberlain M, Kormanik P . Carcinoma meningitis secondary to non-small cell lung cancer: combined modality therapy. Arch Neurol. 1998; 55(4):506-12. DOI: 10.1001/archneur.55.4.506. View